Clinical Trial Update: Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aldosterone blockade in chronic kidney disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Lene Boesby | Conditions: Chronic Kidney Disease | Phase 3 | Status: TERMINATED